Fischer Medical Ventures Ltd. (FISCHER.NS) Stock Overview
Explore Fischer Medical Ventures Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Fischer Medical Ventures Ltd. (FISCHER.NS)
Key Financials
Key Financials
Market Cap
20.9B
P/E Ratio
66.32
EPS (TTM)
$0.45
ROE
0.08%
FISCHER.NS Stock Analysis & Investment Overview (NSE)
Our AI-powered analysis of Fischer Medical Ventures Ltd. (NSE: FISCHER.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Fischer Medical Ventures Ltd.'s NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of FISCHER.NS on the NSE shows an RSI of 27.37, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NSE listing.
Key metrics behind Fischer Medical Ventures Ltd.'s NSE-traded stock include a P/E ratio of 66.32 and a market capitalization of 20.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of FISCHER.NS on the NSE.